CLINICAL_TRIALS
withdrawal
· 2017-10-18
Clinical Trial Update: The Safety of a High-Dose, Rapid Infusion of Iron Sucrose [Phase 2]
Summary
Phase 2 trial evaluating the safety of a high-dose, rapid infusion of iron sucrose for iron deficiency was withdrawn before completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Guthrie Clinic | Conditions: Iron Deficiency | Phase 2 | Status: WITHDRAWN